From the Department of Neurology (P.S.N.), National Neuroscience Institute, Singapore; Department of Neurology (P.S.N., P.J.D., R.S.L., M.V.P., P.J.B.D.), and Division of Biomedical Statistics and Informatics (P.T.), Mayo Clinic, Rochester, MN.
Neurology. 2019 Mar 12;92(11):e1188-e1194. doi: 10.1212/WNL.0000000000007020. Epub 2019 Feb 13.
To determine the previously unknown incidence of lumbosacral radiculoplexus neuropathy (LRPN) and its association with diabetes mellitus (DM).
LRPN defined by clinical and electrophysiologic criteria was identified among Olmsted County, Minnesota, residents during a 16-year period (2000-2015) using the unique facilities of the Rochester Epidemiology Project. DM was ascertained using American Diabetes Association criteria.
Of 1,892 medical records reviewed, 59 patients (33 men, 26 women) were identified as having LRPN. The median age was 70 years (range 24-88 years) and the median time of onset of symptoms to diagnosis was 2 months (range 1-72 months). DM was more frequent in patients with LRPN than in controls (39/59 vs 35/177, < 0.001) but not in those with pre-DM (10/20 vs 55/142, = 0.336). LRPN recurred in 3 patients with DM resulting in 62 LRPN episodes during the study period. The overall incidence of LRPN was 4.16/100,000/y (95% confidence interval [CI] 3.13-5.18). The incidences of LRPN among DM and non-DM groups were 2.79/100,000/y (95% CI 1.94-3.64) and 1.27/100,000/y (95% CI 0.71-1.83), respectively. The odds of LRPN among patients with DM and pre-DM was 7.91 (95% CI 4.11-15.21) and 1.006 (95% CI 1.004-1.012), respectively.
LRPN incidence in Olmsted County of 4.16/100,000/y makes LRPN a common inflammatory neuropathy and is higher than that of other immune-mediated neuropathies (acute or chronic inflammatory demyelinating polyradiculoneuropathy, brachial plexus neuropathy) assessed within the same population. DM is a major risk factor for LRPN and thus justifies the continued classification of LRPN into diabetic and nondiabetic forms.
确定腰骶神经根丛神经病(LRPN)的先前未知发病率及其与糖尿病(DM)的关系。
利用罗切斯特流行病学项目的独特设施,在明尼苏达州奥姆斯特德县的居民中,通过临床和电生理标准确定 LRPN。使用美国糖尿病协会的标准确定 DM。
在审查的 1892 份病历中,发现 59 名患者(33 名男性,26 名女性)患有 LRPN。中位年龄为 70 岁(范围 24-88 岁),症状出现到诊断的中位时间为 2 个月(范围 1-72 个月)。LRPN 患者中 DM 的发生率高于对照组(39/59 与 35/177,<0.001),但低于前驱糖尿病患者(10/20 与 55/142,=0.336)。3 名患有 DM 的患者 LRPN 复发,导致研究期间发生 62 次 LRPN 发作。LRPN 的总体发病率为 4.16/100,000/y(95%置信区间[CI] 3.13-5.18)。DM 和非 DM 组的 LRPN 发病率分别为 2.79/100,000/y(95%CI 1.94-3.64)和 1.27/100,000/y(95%CI 0.71-1.83)。DM 和前驱糖尿病患者发生 LRPN 的几率分别为 7.91(95%CI 4.11-15.21)和 1.006(95%CI 1.004-1.012)。
奥姆斯特德县 LRPN 的发病率为 4.16/100,000/y,使 LRPN 成为一种常见的炎症性神经病,高于同一人群中评估的其他免疫介导性神经病(急性或慢性炎症性脱髓鞘性多神经根神经病、臂丛神经病)。DM 是 LRPN 的主要危险因素,因此有理由将 LRPN 继续分类为糖尿病和非糖尿病形式。